Back to search
FDAFDA · Food and drugs·Recall number Z-0078-2017

TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere® is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters.

Published October 19, 2016 · Recall initiated: September 21, 2015

Summary

FDA records medical device Class II recall Z-0078-2017, published October 19, 2016 and initiated September 21, 2015. Recalling firm: Biocompatibles U.K., Ltd.; Status: Terminated; Reported quantity: 64 doses; Lot: Lot 1599211, Expiry Date: 18SEP2015 (12 days after calibration). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

One mislabeled dose of TheraSphere® Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biocompatibles U.K., Ltd.
Distributor
Worldwide Distribution - US to CA, FL, IL, WI, IN, OR, PA, MA, NY, KY, TX, MI, MD, NV, WA, OH, MN, and Internationally to Germany, Turkey, Hong Kong, Italy, Portugal
Lot
Lot 1599211, Expiry Date: 18SEP2015 (12 days after calibration)
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Related recalls

Questions about this recall

Was TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere® is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters. recalled?

Yes. FDA published recall Z-0078-2017 on October 19, 2016. Reported hazard: One mislabeled dose of TheraSphere® Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone